Dermorphin: 5-10mg*10 vials

Introduction: Dermorphin is a peptide belonging to the family of opioid peptides, known for its potent analgesic properties. It is derived from the skin of certain frog species, particularly the South American tree frog Phyllomedusa sauvagei.

What is Dermorphin? Dermorphin, also referred to as dermorphin-7 or [D-Arg2] dermorphin, is a naturally occurring peptide composed of amino acid residues. It is structurally similar to endogenous opioid peptides found in mammals, such as beta-endorphin.

Potential Different Names:

• Dermorphin-7
• [D-Arg2] dermorphin
• Dermorphin peptide

Chemical Formula: The chemical formula of Dermorphin is C40H50N8O10.

Structure: Dermorphin is a linear peptide consisting of 7 amino acid residues, arranged in a specific sequence. Its structure includes a D-amino acid residue at the second position, which enhances its stability and resistance to enzymatic degradation.

How Does it Work? Dermorphin exerts its effects primarily by interacting with opioid receptors in the central nervous system. It exhibits high affinity and selectivity for the mu-opioid receptor, leading to potent analgesic effects. Upon binding to these receptors, dermorphin modulates neuronal activity and inhibits pain transmission, resulting in pain relief.

Potential Applications:

• Research into pain management and analgesia
• Investigation of opioid receptor pharmacology
• Study of neurophysiological mechanisms underlying pain perception
• Development of novel analgesic agents with improved efficacy and safety profiles

Potential Side Effects:

• Respiratory depression
• Sedation and drowsiness
• Nausea and vomiting
• Constipation
• Tolerance and dependence with prolonged use

Dosage: Dosage information for Dermorphin varies depending on the specific research objectives and experimental models. It is essential to consult scientific literature or seek guidance from qualified researchers for appropriate dosing regimens.

What to Check Before: Before using Dermorphin in research or experimentation, it is crucial to:

• Ensure compliance with ethical guidelines and regulations governing the use of controlled substances
• Verify the purity and integrity of the peptide
• Assess potential interactions with other compounds or experimental conditions

Conclusion: Dermorphin is a promising peptide with potent analgesic properties, offering valuable insights into pain management and opioid pharmacology. Its unique structure and mechanism of action make it a subject of interest in scientific research and therapeutic development.

Disclaimer: Dermorphin is intended for research purposes only and is not for human or veterinary use. It should be handled and used by qualified individuals in accordance with applicable regulations and guidelines.